Search by Drug Name or NDC
NDC 61919-0573-20 BENZONATATE 100 mg/1 Details
BENZONATATE 100 mg/1
BENZONATATE is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Direct_Rx. The primary component is BENZONATATE.
MedlinePlus Drug Summary
Benzonatate is used to relieve cough. Benzonatate is in a class of medications called antitussives (cough suppressants). It works by reducing the cough reflex in the lungs and air passages.
Related Packages: 61919-0573-20Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Benzonatate
Product Information
| NDC | 61919-0573 |
|---|---|
| Product ID | 61919-573_fb33a191-cfaf-8326-e053-6294a90aa68d |
| Associated GPIs | 43102010000105 |
| GCN Sequence Number | 004641 |
| GCN Sequence Number Description | benzonatate CAPSULE 100 MG ORAL |
| HIC3 | H6C |
| HIC3 Description | ANTITUSSIVES, NON-OPIOID |
| GCN | 29840 |
| HICL Sequence Number | 001929 |
| HICL Sequence Number Description | BENZONATATE |
| Brand/Generic | Generic |
| Proprietary Name | BENZONATATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | BENZONATATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | BENZONATATE |
| Labeler Name | Direct_Rx |
| Pharmaceutical Class | Decreased Tracheobronchial Stretch Receptor Activity [PE], Non-narcotic Antitussive [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040627 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 61919-0573-20 (61919057320)
| NDC Package Code | 61919-573-20 |
|---|---|
| Billing NDC | 61919057320 |
| Package | 20 CAPSULE in 1 BOTTLE (61919-573-20) |
| Marketing Start Date | 2019-07-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |